Doctor Care Anywhere Group PLC (ASX: DOC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Doctor Care Anywhere Group PLC Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Doctor Care Anywhere Group PLC (ASX: DOC)
Latest News

Share Market News
Reason for hope as 'worst month of the year' starts off badly

Growth Shares
Is it time to buy these 2 beaten-up ASX shares in April 2022?

Growth Shares
Are these 2 top ASX growth shares buys?

Technology Shares
2 top ASX tech shares for February 2022

Technology Shares
2 ASX tech shares that are rapidly growing

Cheap Shares
Down 50%: Broker tips A2 Milk (ASX:A2M) and this ASX share to rebound in 2022

Small Cap Shares
2 small cap ASX shares for 2022 with big potential

Healthcare Shares
Why Doctor Care Anywhere (ASX:DOC) is soaring 12% today

Healthcare Shares
Why is the Doctor Care Anywhere (ASX:DOC) share price getting attention today?

Growth Shares
2 fast growth ASX shares that could be buys in December 2021

Growth Shares
2 ASX shares that may be too good to ignore

Share Market News
Doctor Care Anywhere (ASX:DOC) share price jumps 6% on record quarter
DOC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Doctor Care Anywhere Group PLC
Doctor Care Anywhere Group PLC is a telehealth company that provides clinical care through digitally enabled, joined-up, evidence-based pathways on its proprietary platform. It utilizes its relationships with health insurers, healthcare providers, and corporate customers to connect with patients to deliver a range of telehealth services. The Group provides virtual healthcare services, technology platform licencing, and digital design services, within the United Kingdom, Australia, and the Republic of Ireland. The company derives the majority of its revenue from the UK and Ireland.
DOC Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
27 Nov 2023 | $0.05 | $0.00 | 0.00% | 50,394 | $0.05 | $0.05 | $0.05 |
24 Nov 2023 | $0.05 | $0.00 | 0.00% | 17,507 | $0.05 | $0.05 | $0.05 |
23 Nov 2023 | $0.05 | $0.00 | 0.00% | 140,280 | $0.05 | $0.05 | $0.05 |
22 Nov 2023 | $0.05 | $0.00 | 0.00% | 154,842 | $0.05 | $0.05 | $0.05 |
21 Nov 2023 | $0.05 | $0.00 | 0.00% | 68,591 | $0.05 | $0.05 | $0.05 |
20 Nov 2023 | $0.05 | $0.00 | 0.00% | 172,920 | $0.05 | $0.05 | $0.05 |
17 Nov 2023 | $0.05 | $0.00 | 0.00% | 40,546 | $0.05 | $0.05 | $0.05 |
16 Nov 2023 | $0.05 | $0.00 | 0.00% | 54,500 | $0.05 | $0.05 | $0.05 |
15 Nov 2023 | $0.05 | $0.00 | 0.00% | 517 | $0.05 | $0.05 | $0.05 |
14 Nov 2023 | $0.05 | $0.00 | 0.00% | 21,924 | $0.05 | $0.05 | $0.05 |
13 Nov 2023 | $0.05 | $0.00 | 0.00% | 76,000 | $0.05 | $0.05 | $0.05 |
10 Nov 2023 | $0.05 | $0.00 | 0.00% | 30,316 | $0.05 | $0.05 | $0.05 |
09 Nov 2023 | $0.05 | $0.00 | 0.00% | 16 | $0.05 | $0.05 | $0.05 |
08 Nov 2023 | $0.05 | $0.00 | 0.00% | 1,708 | $0.05 | $0.05 | $0.05 |
07 Nov 2023 | $0.05 | $0.00 | 0.00% | 44,495 | $0.05 | $0.05 | $0.05 |
06 Nov 2023 | $0.05 | $0.00 | 0.00% | 196,481 | $0.05 | $0.05 | $0.05 |
03 Nov 2023 | $0.05 | $0.00 | 0.00% | 124,252 | $0.05 | $0.05 | $0.05 |
02 Nov 2023 | $0.05 | $0.00 | 0.00% | 211,812 | $0.05 | $0.05 | $0.05 |
01 Nov 2023 | $0.05 | $0.00 | 0.00% | 14,521 | $0.05 | $0.05 | $0.05 |
31 Oct 2023 | $0.05 | $0.00 | 0.00% | 1,243 | $0.05 | $0.05 | $0.05 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
01 Sep 2023 | John Stier | Buy | 1,000,000 | $51,587 |
On-market trade. average
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Ms Romana Abdin | Non-Executive Director | Sep 2020 |
Ms Abdin was appointed as a Non-Executive Director of Doctor Care Anywhere in September 2020. Ms Abdin was CEO of Simplyhealth Group, from 2013 to 2021 and transformed the business from a sole focus on healthcare funding towards a diversified health and wellbeing business. During her time as CEO, Ms Abdin has led the restructuring and investment in digital capability to meet the demands of today's customers, employers and healthcare practitioners, developing new propositions, establishing new relationships, developing people capabilities and a leadership team which has shifted the culture from risk averse and analogue to more customer-centric, agile and highly engaged. Ms Abdin has a strong industry profile in the UK and has gained extensive commercial, board, governance and regulatory experience in previous roles at Simplyhealth, Lloyds Banking Group and Bradford & Bingley Building Society. Ms Abdin started her career as a Barrister in London specialising in corporate and commercial law and went on to hold several corporate affairs and legal roles, principally in the financial services and entertainment sectors.
|
Mr David Ravech | Non-Executive Director | Apr 2015 |
Mr Ravech is a co-founder of Doctor Care Anywhere Group, he served as Chairman of Doctor Care Anywhere until November 2018. For more than 20 years, Mr Ravech has led and invested in disruptive technology companies. Prior to his involvement with Doctor Care Anywhere, Mr Ravech was the founder and CEO of Overland Health (now part of Slater and Gordon Solutions), a technology-driven provider of rehabilitation services. He also founded and was later Co-CEO of Global Freight Exchange which provided the world's leading airlines and freight forwarders with the first online price and availability comparison engine and transaction system for airfreight (with the company being sold in 2007 to Descartes (Nasdaq: DSGX), a provider of cloud-based logistics and supply chain management solutions). Mr Ravech initially qualified as a barrister and solicitor with Arthur Robinson & Hedderwicks (now Allens) working in the Securities, Mergers and Acquisitions group. He then spent six years as a strategy management consultant at McKinsey, based in the Melbourne and London offices. He has worked in Australia, the UK, Japan, Israel and several European countries, primarily serving clients in the retail, brewing, telecoms and banking sectors with a focus on mergers and acquisitions, competition law approvals and pricing strategy.
|
Mr John Robert Stier | Non-Executive Director | May 2022 |
Mr Stier has experience in change management, M&A, and growth in services industries as well as a wealth of finance expertise to DOC's Board. He has been a Group Chief Financial Officer (CFO) at FTSE 250 companies Equiniti Plc and Northgate Information Solutions Plc in the past 20 years. He is currently a Board member and Chair of the Audit and Risk Committee at Redburn, a stockbroking firm based in London. He also chairs Risk Management Committee.
|
Dr Aleksandra Spencer | Non-Executive Director | Jul 2023 |
Dr Spencer brings experience in healthcare and life sciences, digital transformation and innovation as well as organisational governance. Aleksandra has a record of transforming and growing business through innovation. She has experience through working with fortune 500 companies, including HCA Healthcare, Pfizer and Merck to reshape their strategies; enabling them to transform into patient/consumer experience driven organisations that engage with the Healthcare Providers, Payers, and Patients in an innovative, secure and compliant way. Aleksandra spent several years with IBM in the technology and business consulting sector advising a range of clients.
|
Ms Bianca Foster | Company Secretary | Sep 2022 |
-
|
Mr Ben Kent | Interim Chief Executive Officer | Feb 2023 |
-
|
James Warren | Acting Chief Financial Officer |
-
|
|
Bianca Foster | Company Secretary |
-
|
|
Ben Kent | Interim Chief Executive Officer |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
UBS Nominees Pty Ltd | 72,634,741 | 19.81% |
Carani Holdings Limited | 44,264,604 | 12.07% |
Vijay Patel | 26,094,880 | 7.12% |
Citicorp Nominees Pty Limited | 20,889,667 | 5.70% |
Bgf Nominees Limited <Bgf Investments Lp A/C> | 18,042,248 | 4.92% |
Bayju Ashvin Thakar | 12,668,969 | 3.46% |
Bhikhu Patel | 8,698,178 | 2.37% |
Hadston 1 Llp\C | 8,587,773 | 2.34% |
Patagorang Pty Limited | 8,191,201 | 2.23% |
Hsbc Custody Nominees (Australia) Limited Gsco Eca | 5,551,623 | 1.51% |
Xilan Capital Limited | 3,949,773 | 1.08% |
Bgf Nominees Limited <Bgf Ventures Lp A/C> | 3,742,855 | 1.02% |
Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> | 3,182,117 | 0.87% |
Hsbc Custody Nominees (Australia) Limited Gsi Eda | 3,076,872 | 0.84% |
Indigenous Capital Limited | 3,053,920 | 0.83% |
Barnett Waddingham Trustees (1996) Limited <Anthony Banks Ltd P/P A/C> | 2,406,855 | 0.66% |
Barnett Waddingham Trustees (1996) Limited <Hrmp Directors P/Sch A/C> | 2,406,855 | 0.66% |
Barnett Waddingham Trustees (1996) Limited <Mj Rutherford Ltd D/Pf A/C> | 2,406,855 | 0.66% |
Christopher Robin Moore | 2,369,224 | 0.65% |
The Hospitals Contribution Fund Of Australia Limited | 2,245,236 | 0.61% |